These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 11789362

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacologic treatment of calcium calculi.
    Preminger GM.
    Urol Clin North Am; 1987 May; 14(2):325-33. PubMed ID: 3576853
    [Abstract] [Full Text] [Related]

  • 23. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL.
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract] [Full Text] [Related]

  • 24. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY, Peters P, Hurt G, Kadesky M, Fine M, Reisman D, Splann F, Caramela C, Freeman A, Britton F, Sakhaee K, Breslau NA.
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [Abstract] [Full Text] [Related]

  • 25. [Preventive medical treatment of recurrent urinary calcium calculi].
    François B, Trolliet P, Cahen R, Semet MP.
    Nephrologie; 1986 Oct; 7(1):9-12. PubMed ID: 3960261
    [Abstract] [Full Text] [Related]

  • 26. [Randomized trials in the prevention of recurrent calcium oxalate stones].
    Presne C, Monge M, Bataille P, el Esper N, Choukroun G, Fournier A.
    Nephrologie; 2003 Oct; 24(6):303-7. PubMed ID: 14584297
    [Abstract] [Full Text] [Related]

  • 27. [Hypercalciuria and hyperuricosuria causing hematuria in the absence of nephrolithiasis].
    Rodríguez Antolin A, Calahorra FJ, Castro M, Andrés A, Montoyo C, Praga M.
    Actas Urol Esp; 1990 Oct; 14(3):188-91. PubMed ID: 2239394
    [Abstract] [Full Text] [Related]

  • 28. [3 years' experience in the prevention of recurrent calcic nephrolithiasis].
    Tessitore N, D'Angelo A, Pagano F, Loschiavo C, Fabris A, Lupo A, Tasca A, Morachiello P, Valvo E, Previato G, Chiaramonte S, Sidoti O, Maschio G.
    Minerva Nefrol; 1980 Oct; 27(2):267-70. PubMed ID: 7219849
    [No Abstract] [Full Text] [Related]

  • 29. Changes in urine volume accomplished by physicians treating nephrolithiasis.
    Parks JH, Goldfischer ER, Coe FL.
    J Urol; 2003 Mar; 169(3):863-6. PubMed ID: 12576800
    [Abstract] [Full Text] [Related]

  • 30. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY, Fuller C, Sakhaee K, Preminger GM, Britton F.
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [Abstract] [Full Text] [Related]

  • 31. Thiazide diuretics for the treatment of children with idiopathic hypercalciuria and hematuria.
    Hymes LC, Warshaw BL.
    J Urol; 1987 Nov; 138(5):1217-9. PubMed ID: 3669171
    [Abstract] [Full Text] [Related]

  • 32. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK, Maloney ME, Mathias BJ, Pietrow PK, Preminger GM.
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [Abstract] [Full Text] [Related]

  • 33. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
    Odvina CV, Mason RP, Pak CY.
    Am J Ther; 2006 May; 13(2):101-8. PubMed ID: 16645424
    [Abstract] [Full Text] [Related]

  • 34. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides.
    Ljunghall S, Backman U, Danielson BG, Fellström B, Johansson G, Wikström B.
    Scand J Urol Nephrol Suppl; 1980 May; 53():239-52. PubMed ID: 6938001
    [No Abstract] [Full Text] [Related]

  • 35. [Prevention of recurrent calcic nephrolithiasis with thiazides. Clinico-metabolic evaluation].
    Aroldi A, Antonacci A, Bonforte G, Surian M, Macchi E, Cantaluppi A, Graziani G.
    Minerva Nefrol; 1979 May; 26(3):315-9. PubMed ID: 262271
    [No Abstract] [Full Text] [Related]

  • 36. Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials.
    Pak CY.
    Clin Nephrol; 2000 Oct; 54(4):271-5. PubMed ID: 11076102
    [Abstract] [Full Text] [Related]

  • 37. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA, Gonzalez G, Taylor R, Wuermser LA, Pak CY.
    Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
    [Abstract] [Full Text] [Related]

  • 38. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Asplin JR.
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [Abstract] [Full Text] [Related]

  • 39. [Nephrolithiasis in hypercalciuria and hyperparathyroidism].
    Rapado A, de la Calle H, Castrillo JM, Mancha A, Traba ML, Delatte LC.
    MMW Munch Med Wochenschr; 1976 Jun 18; 118(25):799-810. PubMed ID: 819807
    [Abstract] [Full Text] [Related]

  • 40. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W.
    Am J Kidney Dis; 2006 Oct 18; 48(4):546-54. PubMed ID: 16997050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.